By 2035, the International Diabetes Federation estimates that diabetes will affect 592 million people globally. A person with diabetes left untreated will go blind from diabetic retinopathy. The Fred Hollows Foundation will develop a tablet device, known as MARVIN, that will use a mobile diagnostic platform to take high-quality photos of the back of the eye, checking for blinding damage caused by diabetes. MARVIN can be operated by anyone and is a solution for millions of people living in remote communities by providing on-the-spot assessment and diagnosis. In 3 years, 200 MARVIN devices will be deployed, screening 6 million people for diabetic retinopathy per year.
The site could not be loaded because of an error, please check your internet connection and/or reload the page.
Your browser is outdated and may not display all features of this site.